accountJohnson expects to seek approval by 2015:-Bapineuzumab, injection to slow progress of Alzheimer's disease.-Canagliflozin, for Type 2 diabetes. -Sirukumab, injection for rheumatoid arthritis.-Fulranumab, injection for pain caused by osteoarthritis or...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to J&J plans to seek approval soon for key new drugs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account